Drug Pedigree Guidelines and How Software Can Help
Joseph J. Strub and Ashish Labh - July 19, 2006

Introduction

Counterfeit and adulterated drugs are an increasing problem, particularly in the United States. Not only do these activities strip profits from legitimate drug manufacturers, but they can also pose a health risk to the consumer. As a result, the US Food and Drug Administration (FDA) has issued guidelines covering "cradle-to-grave" tracking requirements that pharmaceutical companies must comply with for the drugs they produce. We'll look at a brief description of the pedigree guidelines, compliance options, and outstanding issues...